A Comprehensive Analysis of Prediction of P-Glycoprotein in Tumour Cells, Breast Cancer and Ovarian Cancer Using Machine Learning
- 2 December 2021
- conference paper
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 904-910
Abstract
Multidrug resistance (MDR) - an extensive barrier for successful chemotherapies. Currently, P-gp inhibitors in chemotherapeutic treatments attained better results. This paper focuses on critical review which summarizes the clinical and computational significance of P-glycoprotein role in efficacy of drugs in tumor cells, breast cancer, and ovarian cancer along with challenges in the development of P-gp inhibitors towards anti-cancer therapy. This paper covers systematic review of various computational tools in predicting P-gp in human cells in the context of various cancers.Keywords
This publication has 32 references indexed in Scilit:
- Spectral Clustering Based Fuzzy C-Means Algorithm for Prediction of Membrane Cholesterol from ATP-Binding Cassette Transporters2020
- Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactionsDrug Resistance Updates, 2020
- A novel approach for breast cancer prediction using optimized ANN classifier based on big data environmentHealth Care Management Science, 2019
- Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-GlycoproteinMolecular Pharmaceutics, 2019
- Three-Dimensional MRI Brain Image Analysis on Hadoop Platform2017
- Multiple Drug Transport Pathways through Human P-GlycoproteinBiochemistry, 2015
- Synthesis of indole based novel small molecules and their in vitro anti-proliferative effects on various cancer cell linesTetrahedron Letters, 2014
- Catalytic Transitions in the Human MDR1 P-Glycoprotein Drug Binding SitesBiochemistry, 2012
- ABC Efflux Pump-Based Resistance to Chemotherapy DrugsChemical Reviews, 2009
- p-Glycoprotein expression as a predictor of breast cancer recurrenceAnnals of Surgical Oncology, 1996